Prof. Dr. Max S Topp, Guoqing Wang, Puja Patel, Rushdia Yusuf, David Lavie. "Zilovertamab vedotin plus R-CHP versus polatuzumab vedotin plus R-CHP as first-line therapy in participants with germinal center B-cell diffuse large B-cell lymphoma (DLBCL): The randomized, open-label, Phase 2 waveline-011 Study." Blood, 2025. doi:10.1182/blood-2025-5480